Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents.
Furst
D E
DE
UCLA Medical School, Los Angeles, USA Presbyterian Hospital, Dallas, USA.
Cush
J
J
Kaufmann
S
S
Siegel
J
J
Kurth
R
R
D018501:Antirheumatic Agents / Q000009:adverse effects*; D000995:Antitubercular Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D009894:Opportunistic Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D014374:Tuberculin Test; D014376:Tuberculosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy
D018501:Antirheumatic Agents; D000995:Antitubercular Agents; D007166:Immunosuppressive Agents